|
1
|
Schwartz S, Jiji R, Kerman S, Meekins J
and Cohen MM: Translocation (6;9)(p23;q34) in acute non lymphocytic
leukemia. Cancer Genet Cytogenet. 10:133–138. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the
classification of the acute leukaemias. French-American-British
(FAB) co-operative group. Br J Haematol. 33:451–458. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Soekarman D, von Lindern M, van der Plas
SD, Selleri L, Bartram CR, Martiat P, Culligan D, Padua RA,
Hasper-Voogt KP, Hagemeijer A, et al: Dek-can rearrangement in
translocation (6;9)(p23;q34). Leukemia. 6:489–494. 1992.PubMed/NCBI
|
|
4
|
Slovak ML, Gundacker H, Bloomfield CD,
Dewald G, Appelbaum FR, Larson RA, Tallman MS, Bennett JM,
Stirewalt DL, Meshinchi S, et al: A retrospective study of 69
patients with t(6;9)(p23;q34) AML emphasizes the need for a
prospective, multicenter initiative for rare ‘poor prognosis’
myeloid malignancies. Leukemia. 20:1295–1297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garcon L, Libura M, Delabesse E, Valensi
F, Asnafi V, Berger C, Schmitt C, Leblanc T, Buzyn A and Macintyre
E: DEK-CAN molecular monitoring of myeloid malignancies could aid
therapeutic stratification. Leukemia. 19:1338–1344. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishiyama K, Takami A, Kanda Y, Nakao S,
Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura T, et al:
Allogeneic hematopoietic stem cell transplantation for acute
myeloid leukemia with t(6;9)(p23;q34) dramatically improves the
patient prognosis: A matched-pair analysis. Leukemia. 26:461–464.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lai YY, Li Y, Shi Y, Dang H, He Q, Feng L,
Wang Z, Wang XY, Li N, Liu Q, et al: Characteristics of 11 patients
with acute myeloid leukemia accompanied with karyotype aberration
t(6;9). Zhongguo Shi Yan Xue Ye Xue Za Zhi. 20:1293–1296. 2012.(In
Chinese). PubMed/NCBI
|
|
8
|
Sandahl JD, Coenen EA, Forestier E,
Harbott J, Johansson B, Kerndrup G, Adachi S, Auvrignon A, Beverloo
HB, Cayuela JM, et al: t(6;9)(p22;q34)/DEK-NUP214 rearranged
pediatric myeloid leukemia: An international study of 62 patients.
Haematologica. 99:865–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tarlock K, Alonzo TA, Moraleda PP, Gerbing
RB, Raimondi SC, Hirsch BA, Ravindranath Y, Lange B, Woods WG,
Gamis AS and Meshinchi S: Acute myeloid leukaemia (AML) with
t(6;9)(p23;q34) is associated with poor outcome in childhood AML
regardless of FLT3-ITD status: A report from the Children's
Oncology Group. Br J Haematol1. 166:254–259. 2014. View Article : Google Scholar
|
|
10
|
Wang Y, Xue Y, Chen S, Wu Y, Pan J, Zhang
J and Shen J: A clinical and laboratory study on acute myeloid
leukemia with t(6;9)(p23;q34). Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
27:34–37. 2010.(In Chinese). PubMed/NCBI
|
|
11
|
Gupta M, Kumar Ashok J, Sitaram U, Neeraj
S, Nancy A, Balasubramanian P, Abraham A, Mathews V, Viswabandya A,
George B, et al: The t(6;9)(p22;q34) in myeloid neoplasms: A
retrospective study of 16 cases. Cancer Genet Cytogenet.
203:297–302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harrison CJ, Hills RK, Moorman AV,
Grimwade DJ, Hann I, Webb DK, Wheatley K, de Graaf SS, van den Berg
E, Burnett AK and Gibson BE: Cytogenetics of childhood acute
myeloid leukemia: United kingdom medical research council treatment
trials AML 10 and 12. J Clin Oncol. 28:2674–2681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
von Lindern M, Fornerod M, van Baal S,
Jaegle M, de Wit T, Buijs A and Grosveld G: The translocation
(6;9), associated with a specific subtype of acute myeloid
leukemia, results in the fusion of two genes, dek and can, and the
expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell
Bio. 12:1687–1697. 1992. View Article : Google Scholar
|
|
14
|
Wei S, Wang S, Qiu S, Qi J, Mi Y, Lin D,
Zhou C, Liu B, Li W, Wang Y, et al: Clinical and laboratory studies
of 17 patients with acute myeloid leukemia harboring
t(7;11)(p15;p15) translocation. Leuk Res. 37:1010–1015. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye L, Lin D, Mi YC, Zhang J, Wang Y, Wang
HJ, Wei H, Liu BC, Zhou CL, Li W and Wang JX: Comparison of
EGILl998 and WH02008 criteria for the diagnosis of mixed phenotype
acute leukemia. Zhonghua Xue Ye Xue Za Zhi. 33:286–290. 2012.(In
Chinese). PubMed/NCBI
|
|
16
|
Huang H and Chen J: Chromosome bandings.
Methods Mol Biol. 1541:59–66. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shaffer LG and Tommerup N: ISCN. An
International System of Human Cytogenetic NomenclatureBasel. S.
Karger; 2005
|
|
18
|
Weerts MJA, van Marion R, Helmijr JCA,
Beaufort CM, Krol NMG, Trapman-Jansen AMAC, Dinjens WNM, Sleijfer
S, Jansen MPHM and Martens JWM: Somatic tumor mutations detected by
targeted next generation sequencing in minute amounts of
serum-derived cell-free DNA. Sci Rep. 7:21362017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng J, Li Y, Jia Y, Fang Q, Gong X, Dong
X, Ru K, Li Q, Zhao X, Liu K, et al: Spectrum of somatic mutations
detected by targeted next-generation sequencing and their
prognostic significance in adult patients with acute lymphoblastic
leukemia. J Hematol Oncol. 10:612017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheson BD, Bennett JM, Kopecky KJ, Büchner
T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister
TA, et al: Revised recommendations of the International Working
Group for diagnosis, standardization of response criteria,
treatment outcomes and reporting standards for therapeutic trials
in acute myeloid leukemia. J Clin Oncol. 21:4642–4649. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Li Y, Yuan T, Zhang Q, Jia Y, Li Q,
Huai L, Yu P, Tian Z, Tang K, et al: Exogenous expression of WT1
gene influences U937cell biological behaviors and activates MAPK
and JAK-STAT signaling pathways. Leuk Res. 38:931–939. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oyarzo MP, Lin P, Glassman A, Bueso-Ramos
CE, Luthra R and Medeiros LJ: Acute myelogenous leukemia with
t(6;9)(p23;q34) is associated with dysplasia and a high frequency
of FLT3 gene mutations. Am J Clin Pathol. 122:348–358. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chi Y, Lindgren V, Quigley S and Gaitonde
S: Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow
basophilia: An overview. Arch Pathol Lab Med. 132:1835–1837.
2008.PubMed/NCBI
|
|
24
|
Vardiman JW, Thiele J, Arber DA, Brunning
RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM,
Hellström-Lindberg E, Tefferi A and Bloomfield CD: The 2008
revision of the World Health Organization (WHO) classification of
myeloid neoplasms and acute leukemia: Rationale and important
changes. Blood. 114:937–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
